- Home
- WALD vs ARCT Comparison
WALD vs ARCT Comparison
Compare WALD & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WALD
- ARCT
- Stock Information
- Founded
- WALD 1988
- ARCT 2013
- Country
- WALD United Kingdom
- ARCT United States
- Employees
- WALD N/A
- ARCT N/A
- Industry
- WALD Package Goods/Cosmetics
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- WALD Consumer Discretionary
- ARCT Health Care
- Exchange
- WALD Nasdaq
- ARCT Nasdaq
- Market Cap
- WALD 372.2M
- ARCT 444.5M
- IPO Year
- WALD 2021
- ARCT N/A
- Fundamental
- Price
- WALD $3.10
- ARCT $13.90
- Analyst Decision
- WALD Strong Buy
- ARCT Strong Buy
- Analyst Count
- WALD 4
- ARCT 7
- Target Price
- WALD $5.95
- ARCT $57.80
- AVG Volume (30 Days)
- WALD 38.6K
- ARCT 450.0K
- Earning Date
- WALD 04-29-2025
- ARCT 03-06-2025
- Dividend Yield
- WALD N/A
- ARCT N/A
- EPS Growth
- WALD N/A
- ARCT N/A
- EPS
- WALD N/A
- ARCT N/A
- Revenue
- WALD $240,382,000.00
- ARCT $152,310,000.00
- Revenue This Year
- WALD $27.29
- ARCT $17.02
- Revenue Next Year
- WALD $19.54
- ARCT $83.01
- P/E Ratio
- WALD N/A
- ARCT N/A
- Revenue Growth
- WALD N/A
- ARCT N/A
- 52 Week Low
- WALD $2.41
- ARCT $12.75
- 52 Week High
- WALD $7.54
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- WALD 43.87
- ARCT 39.01
- Support Level
- WALD $3.02
- ARCT $12.75
- Resistance Level
- WALD $3.27
- ARCT $14.78
- Average True Range (ATR)
- WALD 0.18
- ARCT 1.18
- MACD
- WALD -0.00
- ARCT -0.26
- Stochastic Oscillator
- WALD 16.98
- ARCT 22.64
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. It is organized into two reportable segments namely Obagi Skincare and Milk Makeup.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.